Antifungal Drugs Market Analysis by Drug Type (Azoles, Allylamines, Echinocandins, Polyenes), Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis), and Region - Forecast to 2029

Request Sample Page

The global antifungal drugs market size was estimated to be USD 12.93 billion in 2021 and is expected to witness a CAGR of 4.30% during the forecast period. Major factors responsible for the growth of this market are increase in hospital-acquired infections; rising awareness about fungal infections around the skin, mouth, eye, and vagina; ease of availability of over-the-counter drugs; and increase in public-private collaborations in the pharmaceutical industry. However, factors such as increasing approvals for generic drugs, patent expiration of innovator drugs, and growing menace of counterfeit drugs are responsible for restraining the market growth.

Global Antifungal Drugs Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Drug Type

Based on drug type, the market is segmented into azoles, echinocandins, allylamines, and polyenes. In 2021, the azoles antifungal class held the dominant position in the market with leading therapeutics drugs Noxafil, Cresemba, Vfend, and Diflucan. Triazoles have a wide range of applications in the treatment of superficial and systemic fungal infections. However, echinocandins, allylamines, and polyenes are expected to witness lucrative growth over the forecast period. This can be attributed to increase in incidence of dermatological infections.

By Therapeutic Indication

Based on therapeutic indication, the market is categorized into aspergillosis, dermatophytosis, and candidiasis. In 2021, dermatophytosis segment accounted for the highest revenue share due to increasing skin infections cases. Candidiasis is a most common blood stream fungal infection caused by yeast and it is expected to grow at the fastest CAGR over the forecast period.

Regional Insights

In 2021, North America held a dominant position in terms of revenue and is anticipated to continue to dominate over the forecast period. This is attributed to rising prevalence of infectious diseases and hospital-acquired infections and presence of major players that are investing on R&D, clinical trials for novel innovative drug developments, & expanding their global reach. Asia Pacific is projected to grow at the highest CAGR over the forecast period due to large population base, availability of drugs, and high unmet clinical needs.

Competitor Insights

Some of the key players in the Antifungal Drugs Market are Pfizer, (U.S.), Merck & Co. (U.S.), GlaxoSmithKline (UK), Astellas Pharma (Japan), Bayer (Germany), Sanofi (France), Novartis(Switzerland), Gilead Sciences (U.S.), Abbott Laboratories (U.S.), and Scynexis(U.S.). Major players operating in the antifungal drug market are adopting growth strategies such as new product development, and mergers and acquisitions to increase their global market reach by providing advanced drugs.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The Antifungal Drugs Market report is categorized into the following segments and subsegments:

Antifungal Drugs Market, By Drug Type (Revenue, 2021-2029, USD Billion)

  • Azoles
    • Triazoles
      • Fluconazole
      • Itraconazole
      • Voriconazole
      • Posaconazole
      • Isavuconazole
    • Imidazoles
      • Ketoconazole
  • Echinocandins
    • Micafungin (Mycamine)
    • Caspofungin ( Cancidas)
    • Anidulafungin (Eraxis)
  • Allylamines
    • Naftifine
    • Terbinafine
  • Polyenes
    • Amphotericin
    • Nystatin
    • Candicidin

Antifungal Drugs Market, By Therapeutic Indication (Revenue, 2021-2029, USD Billion)

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
    • Oral
    • Vaginal
    • Vulvovaginal (VVC)
    • Esophageal

Antifungal Drugs Market, By Region (Revenue, 2021-2029, USD Billion)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Antifungal Drugs Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Antifungal Drugs Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  2. Introduction: Antifungal Drugs
  3. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  4. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  5. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  6. COVID-19 Impact Analysis: Antifungal Drugs Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  7. Market Analysis by Drug class
    1. Echinocandins
      1. Echinocandins Market Forecast, 2021-2029 (USD Million)
    2. Allylamines
      1. Allylamines Market Forecast, 2021-2029 (USD Million)
    3. Polyenes
      1. Polyenes Market Forecast, 2021-2029 (USD Million)
    4. Azoles
      1. Azoles Market Forecast, 2021-2029 (USD Million)
    5. Other
      1. Other Market Forecast, 2021-2029 (USD Million)
  8. Market Analysis by Indication
    1. Aspergillosis
      1. Aspergillosis Market Forecast, 2021-2029 (USD Million)
    2. Candidiasis
      1. Candidiasis Market Forecast, 2021-2029 (USD Million)
    3. Dermatophytosis
      1. Dermatophytosis Market Forecast, 2021-2029 (USD Million)
    4. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  9. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  10. North America Antifungal Drugs Market
    1. North America Antifungal DrugsMarket
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
      2. S. Antifungal DrugsMarket
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
        2. Canada Antifungal DrugsMarket
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
  11. Europe Antifungal Drugs Market
    1. Europe Antifungal DrugsMarket
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
      2. Germany Antifungal DrugsMarket
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
        2. UK Antifungal DrugsMarket
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
          2. France Antifungal DrugsMarket
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
            2. Spain Antifungal DrugsMarket
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
              2. Italy Antifungal DrugsMarket
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
                2. Rest of Europe Antifungal DrugsMarket
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
  12. Asia Pacific Antifungal Drugs Market
    1. Asia Pacific Antifungal DrugsMarket
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
      2. Japan Antifungal DrugsMarket
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
        2. China Antifungal DrugsMarket
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
          2. India Antifungal DrugsMarket
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
            2. South Korea Antifungal DrugsMarket
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
                3. Market Size and Forecast by Device, 2021-2029 (USD Million)
              2. Australia Antifungal DrugsMarket
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Antifungal DrugsMarket
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
  13. Latin America Antifungal Drugs Market
    1. Latin America Antifungal DrugsMarket
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
      2. Brazil Antifungal DrugsMarket
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
        2. Mexico Antifungal DrugsMarket
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
          2. Argentina Antifungal DrugsMarket
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
            2. Rest of Latin America Antifungal DrugsMarket
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
  14. MEA Antifungal Drugs Market
    1. MEA Antifungal DrugsMarket
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
    2. GCC Antifungal DrugsMarket
      1. GCC Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
    3. South Africa Antifungal DrugsMarket
      1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
    4. Rest of MEA Antifungal DrugsMarket
      1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
  15. Competitor Analysis
    1. Market Share Analysis, 2020 & 2031
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  16. Company Profiles
    1. GlaxoSmithKline (U.K.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Boehringer Ingelheim GmbH (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. 3M (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. AstraZeneca plc (U.K.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Merck & Co., Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Novartis AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Omron Corporation (Japan)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Sunovion Pharmaceuticals Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Novus International, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. BASF SE (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports